Innocoll surgical adhesion barrier wins European approval

13 October 2011 (Last Updated October 13th, 2011 18:30)

Innocoll has secured European approval for its CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery.

Innocoll has secured European approval for its CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery.

CollaGUARD is a transparent bioresorbable film of 100% type I collagen, developed using Innocoll's proprietary CollaFilm technology.

The adhesion barrier is implanted at the time of surgery and serves as a temporary barrier to separate apposing adhesiogenic surfaces throughout the normal tissue repair process.

When tested in vivo, CollaGUARD increased the probability of remaining adhesion-free by more than six-fold, and reduced the extent and severity of adhesions.

The company also plans to seek approval in Australia, Canada, the Middle East, North Africa and south-east Asia.

It will also initiate the studies required for registration in the US.